Clinical Trial: A Trial of AGMB-447 in Participants With Idiopathic Pulmonary Fibrosis

U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07862634) titled 'A Trial of AGMB-447 in Participants With Idiopathic Pulmonary Fibrosis' on Sept. 15.

Brief Summary: The main goal of this clinical trial is to find out if an experimental inhaled drug, AGMB-447, can help improve lung function in people living with a lung disease called idiopathic pulmonary fibrosis (IPF). To do this, the effects of the study drug will be compared to a placebo, which is a treatment that looks like the study drug but contains no active medicine.

The specific goals of the trial are as follows:

Primary Objective and Estimand: The main goal is to see if 24 weeks of treatment with AGMB-447 helps the lungs work better tha...